Cancer Vaccines and Immunotherapy
A section of Vaccines (ISSN 2076-393X).
Keywords
- Tumor immunology
- Immune checkpoint inhibitors
- T cells
- Animal models
- Immunophenotype
- Mass cytometry
- Immune signature
- Immune score
- Immune cells
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Dendritic Cells (DCs) and Cancer Immunotherapy (Deadline: 31 July 2025)
- Vaccines Targeting the Tumor Microenvironment: Challenges and Future Prospects (Deadline: 31 August 2025)
- Modulating CD4+ T Cells for Cancer Immunotherapy: Emerging Strategies and Applications (Deadline: 1 September 2025)
- Innovations in Immunotherapy: Advancements in Cancer Vaccines and Immune Modulation (Deadline: 30 September 2025)
- Innovative Vaccines That Modulate the Immune System to Enhance Cancer Therapy (Deadline: 31 October 2025)
- Vaccines Targeting Dendritic Cells (Deadline: 31 October 2025)
- Personalised Cancer Vaccines (Deadline: 31 October 2025)
- Cancer Vaccines and Immunotherapy: Latest Advances, Limitations and Prospects (Deadline: 30 November 2025)
- Cutting-Edge Cancer Vaccines Enhanced by Nanotechnology (Deadline: 31 December 2025)
- Vaccination or Infection and the Role of T Cells—the Response to Cancer, Autoimmunity or Inflammatory Diseases (Deadline: 31 December 2025)
- Next-Generation Vaccine and Immunotherapy (Deadline: 31 January 2026)
- The Era of Vaccines: Advancing Tumor Immunology and Immunotherapy (Deadline: 31 January 2026)
- Novel Immunotherapies, Cell Therapies and Cancer Vaccines (Deadline: 31 January 2026)
- Cancer Vaccines: Current Advances, Clinical Applications, and Future Directions (Deadline: 28 February 2026)
- Advances in Cancer Immunotherapy and Vaccines Research: 2nd Edition (Deadline: 20 March 2026)
- Cancer Vaccines: 4th Edition (Deadline: 31 March 2026)
- Cancer Vaccines and Immunotherapies (Deadline: 31 March 2026)
- Oral Vaccines: Challenges, Immunity and Therapeutic Advances (Deadline: 30 April 2026)
- Tumor Vaccines: Current Processes, Prevailing Challenges and Future Perspectives (Deadline: 1 May 2026)
- Vaccines Based on Dendritic Cells: Breaking Barriers to New Immune Response Approach (Deadline: 31 May 2026)
- Therapeutic Cancer Vaccines: Advances, Challenges, and Future Directions (Deadline: 31 May 2026)
- Advances in ImmunoTherapy of Cancer (Deadline: 31 May 2026)
- Vaccination for Patients with Hematologic Diseases (Deadline: 31 August 2026)
